第一作者单位：[1]Huazhong Univ Sci & Technol,Tongji Hosp,Dept & Inst Infect Dis,Tongji Med Coll,Wuhan,Peoples R China[2]Huazhong Univ Sci & Technol, State Key Lab Diag & Treatment Severe Zoonost Infe, Wuhan, Peoples R China
通讯作者：
通讯机构：[1]Huazhong Univ Sci & Technol,Tongji Hosp,Dept & Inst Infect Dis,Tongji Med Coll,Wuhan,Peoples R China[2]Huazhong Univ Sci & Technol, State Key Lab Diag & Treatment Severe Zoonost Infe, Wuhan, Peoples R China[3]Huazhong Univ Sci & Technol,Tongji Hosp,Dept & Inst Infect Dis,Tongji Med Coll,Wuhan 430030,Hubei,Peoples R China[4]Huazhong Univ Sci & Technol, State Key Lab Diag & Treatment Severe Zoonost Infe, Wuhan 430030, Hubei, Peoples R China
推荐引用方式(GB/T 7714)：
Wu Di,Huang Da,Yan Weiming,et al.Response to: Comment on 'End-of-treatment HBcrAg and HBsAb levels identify durable functional cure after Peg-IFN- based therapy in patients with CHB'[J].JOURNAL OF HEPATOLOGY.2023,79(5):E204-E206.doi:10.1016/j.jhep.2023.08.001.
APA：
Wu, Di,Huang, Da,Yan, Weiming&Ning, Qin.(2023).Response to: Comment on 'End-of-treatment HBcrAg and HBsAb levels identify durable functional cure after Peg-IFN- based therapy in patients with CHB'.JOURNAL OF HEPATOLOGY,79,(5)
MLA：
Wu, Di,et al."Response to: Comment on 'End-of-treatment HBcrAg and HBsAb levels identify durable functional cure after Peg-IFN- based therapy in patients with CHB'".JOURNAL OF HEPATOLOGY 79..5(2023):E204-E206
医学